By timothy from Slashdot's improved-throughput-explains-all department
writes "Last year it took almost an hour, but this morning Google's enormously popular conference for developers sold out in about 20 minutes, Vic Gundotra, Google's senior vice president of engineering, told his followers on Google+. 'While we're overwhelmed with the interest and enthusiasm around Google I/O, we know it can be very disappointing and frustrating when an event sells out this quickly,' he wrote. Those who did not get tickets were not only disappointed and angry, but mystified as to why they were left out of a first-come, first-served sale despite being online and ready to buy the second the bell rang. And, of course, tickets were quickly being scalped on eBay."
Of course, everyone who gets in drives away in a free Tesla.Read Replies (0)
By Unknown Lamer from Slashdot's confused-mice-with-foot-tumors department
sciencehabit writes, quoting an article in Science
: "A single drug can shrink or cure human breast, ovary, colon, bladder, brain, liver, and prostate tumors that have been transplanted into mice, researchers have found. The treatment, an antibody that blocks a 'do not eat' signal normally displayed on tumor cells, coaxes the immune system to destroy the cancer cells."
The abstract and full paper
are freely available. It seems fairly promising: "In mice given human bladder cancer tumors, for example, 10 of 10 untreated mice had cancer that spread to their lymph nodes. Only one of 10 mice treated with anti-CD47 had a lymph node with signs of cancer. Moreover, the implanted tumor often got smaller after treatment — colon cancers transplanted into the mice shrank to less than one-third of their original size, on average. And in five mice with breast cancer tumors, anti-CD47 eliminated all signs of the cancer cells, and the animals remained cancer-free 4 months after the treatment stopped."Read Replies (0)